Holen Sie sich die Stockscreener-App
0.411
5.30%
0.0207
Handel nachbörslich:
.40
-0.011
-2.68%
Schlusskurs vom Vortag:
$0.3903
Offen:
$0.3864
24-Stunden-Volumen:
519.39K
Relative Volume:
0.04
Marktkapitalisierung:
$8.86M
Einnahmen:
$414.60K
Nettoeinkommen (Verlust:
$-19.21M
KGV:
-0.2536
EPS:
-1.6207
Netto-Cashflow:
$-4.89M
1W Leistung:
+2.19%
1M Leistung:
-10.26%
6M Leistung:
+7.23%
1J Leistung:
-81.49%
1-Tages-Spanne:
$0.3753
$0.4222
1-Wochen-Bereich:
$0.373
$0.4222
52-Wochen-Spanne:
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.411 | 8.32M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Mangoceuticals Terminates Planned Business Combination with Nuclea - TipRanks
Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView
Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView
Mangoceuticals Company Profile & Introduction - Moomoo
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesEarnings Yield Analysis - vinanet.vn
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Bitcoin miner explores modular reactors for up to 100 MWe - Stock Titan
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
$Mangoceuticals (MGRX.US)$ - Moomoo
MGRX Q3 2025 Earnings: Reported EPS of -$0.69 as Shares Rally 89.75%Earnings Forecast Report - vinanet.vn
Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com
That’s quite fortunate! - Moomoo
$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com
$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo
Mangoceuticals (NASDAQ:MGRX) Shares Surge Almost Threefold Following Nuclea Agreement; Existing Shareholders Retain 4% - TechStock²
Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada
Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - TMX Newsfile
Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de
Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria
Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada
Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView
User - The Chronicle-Journal
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mangoceuticals Inc (MGRX) Cash Flow - TradingKey
Mangoceuticals Inc (MGRX) Income Statement - TradingKey
MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey
MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mangoceuticals Inc-Aktie (MGRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
0.03%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):